Once again last week the market was hitting all-time highs, and once again insiders were selling shares at a furious pace. Who can blame them? While the outlook for 2017 is bright, and President Trump is signaling that positives like tax cuts are on the horizon, the bottom line is stock prices are sky-high and insiders know it.
We cover insider selling every week at 24/7 Wall St., and we like to remind readers that just because an individual or 10% institutional owner sells stock, that is no cause for immediate alarm. Many top executives, and even directors, are compensated with stock and often sell just to diversify portfolios or purchase other assets.
Here are companies that reported notable insider selling this past week.
Hedge Fund Value Act was a huge technology seller this past week. It parted with an 11 million share block of Microsoft Corp. (NASDAQ: MSFT). The shares were priced between $63.12 and $63.77 apiece, and the total for the sale was an incredible $697 million. The shares closed last Friday at $64.00. The 52-week trading range for the software and cloud giant is $48.04 to $65.91. The Wall Street consensus price target for the stock is $68.97.
Top Value Stocks To Watch Right Now: Consumer Portfolio Services Inc.(CPSS)
Advisors' Opinion:- [By Stephan Byrd]
ValuEngine upgraded shares of Consumer Portfolio Services (NASDAQ:CPSS) from a sell rating to a hold rating in a report issued on Tuesday.
Other research analysts also recently issued research reports about the company. Jefferies Financial Group reaffirmed a buy rating and issued a $5.00 price target on shares of Consumer Portfolio Services in a research note on Thursday, July 26th. Zacks Investment Research upgraded Consumer Portfolio Services from a sell rating to a hold rating in a research report on Monday, August 27th. Finally, JMP Securities upgraded Consumer Portfolio Services from a market perform rating to an outperform rating and set a $6.00 target price on the stock in a research report on Friday, June 8th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and two have given a buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $5.08.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Consumer Portfolio Services (CPSS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top Value Stocks To Watch Right Now: Pentair plc.(PNR)
Advisors' Opinion:- [By Stephan Byrd]
Pentair PLC (NYSE:PNR) was the recipient of a significant growth in short interest in May. As of May 31st, there was short interest totalling 3,588,294 shares, a growth of 49.3% from the May 15th total of 2,403,699 shares. Currently, 2.0% of the shares of the stock are short sold. Based on an average trading volume of 1,381,350 shares, the days-to-cover ratio is presently 2.6 days.
- [By Shane Hupp]
Pentair (NYSE:PNR) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, July 25th. Analysts expect the company to announce earnings of $1.12 per share for the quarter.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Pentair (PNR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Suntrust Banks Inc. boosted its stake in shares of Pentair PLC (NYSE:PNR) by 49.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,328 shares of the industrial products company’s stock after buying an additional 2,411 shares during the period. Suntrust Banks Inc.’s holdings in Pentair were worth $498,000 as of its most recent filing with the Securities & Exchange Commission.
- [By Logan Wallace]
nVent Electric (NYSE: NVT) and Pentair (NYSE:PNR) are both mid-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, earnings, analyst recommendations and dividends.
- [By Joseph Griffin]
Pentair (NYSE:PNR)‘s stock had its “equal weight” rating reaffirmed by analysts at KeyCorp in a research note issued to investors on Thursday.
Top Value Stocks To Watch Right Now: Liquidity Services Inc.(LQDT)
Advisors' Opinion:- [By Joseph Griffin]
Eagle Boston Investment Management Inc. grew its stake in Liquidity Services, Inc. (NASDAQ:LQDT) by 4.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 307,736 shares of the business services provider’s stock after purchasing an additional 12,917 shares during the quarter. Eagle Boston Investment Management Inc. owned approximately 0.96% of Liquidity Services worth $2,015,000 as of its most recent SEC filing.
- [By Stephan Byrd]
Liquidity Services (NASDAQ:LQDT) last issued its quarterly earnings data on Thursday, May 3rd. The business services provider reported ($0.12) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.02. Liquidity Services had a negative net margin of 12.72% and a negative return on equity of 19.31%. The company had revenue of $43.10 million during the quarter, compared to the consensus estimate of $60.16 million. equities analysts forecast that Liquidity Services, Inc. will post -0.71 earnings per share for the current year.
- [By Lisa Levin]
Losers Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering. InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday. Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81. Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections. Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results. LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss. Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit. Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings. Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss. Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight. Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings. The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results. Arcadia Biosciences, Inc. (N
No comments:
Post a Comment